Helen Torley Insider Trading $ONXX ONYX PHARMACEUTICALS INC
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Helen Torley.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Helen Torley. Helen Torley is Chief Opertaing Officer in ONYX PHARMACEUTICALS INC ($ONXX) and EVP & Chief Commercial Officer in ONYX PHARMACEUTICALS INC ($ONXX) and Director in QUEST DIAGNOSTICS INC ($DGX) and President and CEO in HALOZYME THERAPEUTICS INC ($GYHT) and Director in Relypsa Inc ($RLYP).
Helen Torley in ONYX PHARMACEUTICALS INC
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Helen Torley: EVP & Chief Commercial Officer, Chief Opertaing Officer
Holdings: 58,701 shares
Latest Transaction: Aug 08 2012
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Helen Torley in ONYX PHARMACEUTICALS INC
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, GYHT, ONXX, DGX, RLYP
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 08 2012 | ONXX | ONYX PHARMACEUTICA ... | Torley Helen | EVP & Chief Commerc ... | Sell | S | 71.89 | 2,000 | 143,780 | 58,701 | 60.7 K to 58.7 K (-3.29 %) |
| Jul 27 2012 | ONXX | ONYX PHARMACEUTICA ... | Torley Helen | Chief Opertaing Off ... | Sell | S | 73.97 | 4,549 | 336,498 | 60,701 | 65.3 K to 60.7 K (-6.97 %) |
| Apr 03 2012 | ONXX | ONYX PHARMACEUTICA ... | Torley Helen | Chief Opertaing Off ... | Option Exercise | A | 37.68 | 18,300 | 689,544 | 18,300 | |
| Apr 03 2012 | ONXX | ONYX PHARMACEUTICA ... | Torley Helen | Chief Opertaing Off ... | Grant | A | 0.00 | 17,150 | 0 | 65,250 | 48.1 K to 65.3 K (+35.65 %) |
| Apr 03 2012 | ONXX | ONYX PHARMACEUTICA ... | Torley Helen | Chief Opertaing Off ... | Grant | A | 0.00 | 3,600 | 0 | 48,100 | 44.5 K to 48.1 K (+8.09 %) |
| Oct 27 2011 | ONXX | ONYX PHARMACEUTICA ... | Torley Helen | Chief Opertaing Off ... | Grant | A | 0.00 | 10,000 | 0 | 44,500 | 34.5 K to 44.5 K (+28.99 %) |
| Aug 31 2011 | ONXX | ONYX PHARMACEUTICA ... | Torley Helen | Chief Opertaing Off ... | Option Exercise | A | 33.70 | 84,000 | 2,830,800 | 84,000 | |
| Aug 31 2011 | ONXX | ONYX PHARMACEUTICA ... | Torley Helen | Chief Opertaing Off ... | Grant | A | 0.00 | 22,500 | 0 | 34,500 | 12 K to 34.5 K (+187.50 %) |
| Aug 31 2011 | ONXX | ONYX PHARMACEUTICA ... | Torley Helen | Chief Opertaing Off ... | Grant | A | 0.00 | 12,000 | 0 | 12,000 | 0 to 12 K |
Page: 1